Decrease in New Cancer Diagnoses Seen in 2020
There was a decrease in new cancer diagnoses, relative to expected numbers, between March 2020 and May 2020, according to a report.
There was a decrease in new cancer diagnoses, relative to expected numbers, between March 2020 and May 2020, according to a report.
Adding nimotuzumab to treatment with gemcitabine improves survival outcomes in patients with KRAS wild-type advanced pancreatic cancer, a phase 3 trial suggests.
Patients from racial and ethnic minority groups are still underrepresented in cancer research, despite efforts to make clinical trials more diverse.
In a pan-cancer analysis, patients with pancreatic acinar cell carcinoma had the highest prevalence of BRCA2 germline pathogenic variants.
Divarasib produced responses in patients with non-small cell lung cancer, colorectal cancer, and other solid tumors in a phase 1 trial.
Active smoking is associated with shorter overall survival in pancreatic cancer patients treated with neoadjuvant FOLFIRINOX, a study suggests.
Lorazepam use may impact progression-free survival and overall survival in patients with a range of cancers, new research suggests.
Black and Hispanic patients have a higher risk of death from second primary cancers than White and Asian/Pacific Islander patients, new data suggest.
SeekInCare, a blood-based multi-cancer detection test, can detect more than 20 cancer types with high specificity, according to researchers.
A study of patients in Texas suggests that surgery is underutilized for the treatment of resectable pancreatic ductal adenocarcinoma.